XML 67 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
Supplemental Consolidated Balance Sheet Information (Details) - Schedule of accrued expenses and other current liabilities - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule Of Accrued Expenses And Other Current Liabilities Abstract      
Sales tax payable [1] $ 5,756 $ 5,290  
Accrued construction costs 5,661 8,803  
Accrued acquisition liability [1],[2] 4,145 9,198  
Compensation related fees 3,141 3,491  
Accrued warranty costs 540 398
Accrued professional fees 448 1,104  
Accrued interest expense 263    
Accrued inventory purchases 243 201  
Financing lease liabilities 153 156  
Accrued consulting fees 90 75  
Accrued non-income taxes 48  
Other current liabilities 65  
Total accrued expenses and other current liabilities $ 20,505 $ 28,764  
[1] Sales tax payable primarily represents identified sales and use tax liabilities arising from the acquisition of Precision and Cascade. These amounts are included as part of the initial purchase price allocations and are the subject matter of an indemnification claim under the Precision and Cascade acquisition agreement.
[2] Accrued acquisition liabilities include both the contingent consideration and the value of held-back Common Stock associated with the 2022 acquisition of Lab Society and the 2021 acquisition of PurePressure.